Cargando…

International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale

INTRODUCTION: As new topical and systemic treatments become available for atopic dermatitis (AD), there is a need to understand how treatments are being used in routine clinical practice, their comparative effectiveness and their long-term safety in diverse clinical settings. METHODS AND ANALYSIS: T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abuabara, Katrina, Silverberg, Jonathan I, Simpson, Eric L, Paller, Amy S, Eichenfield, Lawrence F., Bissonnette, Robert, Krueger, James, Harris, John E., Dalfonso, Laura, Watkins, Stephanie E, Crawford, Julie M, Thaçi, D, Guttman-Yassky, Emma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Dermatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703415/ https://www.ncbi.nlm.nih.gov/pubmed/33247014 http://dx.doi.org/10.1136/bmjopen-2020-039928

Ejemplares similares

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology
por: Paller, Amy S, et al.
Publicado: (2020)

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
por: Simpson, Eric L., et al.
Publicado: (2022)

Dermatology for the internist: optimal diagnosis and management of atopic dermatitis
por: Narla, Shanthi, et al.
Publicado: (2021)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019)

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial
por: Guttman-Yassky, Emma, et al.
Publicado: (2020)

Epidemiology of atopic dermatitis in Europe
por: Kowalska-Olędzka, Elżbieta, et al.
Publicado: (2019)

Systematic review of atopic dermatitis disease definition in studies using routinely collected health data
por: Dizon, M.P., et al.
Publicado: (2018)

Management of Atopic Dermatitis: The Role of Tacrolimus
por: Umar, Badar Uddin, et al.
Publicado: (2022)

Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families
por: Simpson, Eric L., et al.
Publicado: (2018)

Relationship Between Atopic Dermatitis and Food Allergy in Children
por: Mehta, Yash, et al.
Publicado: (2022)

Exacerbation of Atopic Dermatitis Associated with Ustekinumab Treatment in Crohn's Disease
por: Andres, Brendan, et al.
Publicado: (2022)

Successful use of ustekinumab therapy in refractory severe atopic dermatitis
por: Shroff, Anjali, et al.
Publicado: (2014)

Epidemiology and management of atopic dermatitis in England: an observational cohort study protocol
por: de Lusignan, Simon, et al.
Publicado: (2020)

Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
por: Tameez Ud Din, Ahsan, et al.
Publicado: (2020)

Managing the Skin Microbiome as a New Bacteriotherapy for Inflammatory Atopic Dermatitis
por: Dewi, Dian Andriani Ratna, et al.
Publicado: (2023)

Review of Prominent Cytokines as Superior Therapeutic Targets for Moderate-to-Severe Atopic Dermatitis
por: Hassan, Zaira, et al.
Publicado: (2020)

The Cross-Talk Between Atopic Dermatitis and Diabetes Mellitus: A Meta-Analysis
por: Mirghani, Hyder O, et al.
Publicado: (2021)

Assessment and Management of Atopic Dermatitis in Primary Care Settings: A Systematic Review
por: Alqahtani, Saad M, et al.
Publicado: (2023)

Effect of treatments on skin microbiota in patients with atopic dermatitis: a protocol for systematic review
por: Guo, Yang, et al.
Publicado: (2022)

Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics
por: Mansouri, Yasaman, et al.
Publicado: (2015)

Dupilumab-Associated Head and Neck Dermatitis With Ocular Involvement in a Ten-Year-Old With Atopic Dermatitis: A Case Report and Review of the Literature
por: Samia, Arthur M, et al.
Publicado: (2022)

Systemic immunomodulatory treatments for atopic dermatitis: protocol for a systematic review with network meta-analysis
por: Drucker, Aaron Mark, et al.
Publicado: (2018)

Can Platelet-Rich Plasma Reduce the Burden of Inflammatory Skin Diseases Such as Psoriasis and Atopic Dermatitis?
por: Kauhl, Winfried, et al.
Publicado: (2021)

Underlying Immune Mechanisms Involved in Cow’s Milk-Induced Hypersensitivity Reactions Manifesting as Atopic Dermatitis
por: Weimer, Derek S, et al.
Publicado: (2022)

Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment
por: Thomas, Caitlin, et al.
Publicado: (2022)

Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study
por: Hedderson, Monique M, et al.
Publicado: (2023)

Recent Advances in Atopic Dermatitis
por: Reynolds, Nicholas J
Publicado: (1997)

Young adults’ perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study
por: Lundin, Susanne, et al.
Publicado: (2021)

Development of Café-Au-Lait-Macule Lesions in a Patient After Dupilumab Therapy for Atopic Dermatitis
por: Hasanain, Afnan, et al.
Publicado: (2023)

Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways
por: Ewald, David A., et al.
Publicado: (2015)

Comparison of treatment standards in Atopic Dermatitis management across selected geographies prior to emerging targeted therapies onset
por: Kowalska-Olędzka, Elżbieta, et al.
Publicado: (2019)

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
por: Marín-Candón, Alicia, et al.
Publicado: (2023)

IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis
por: Callewaert, Chris, et al.
Publicado: (2019)

Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials
por: Paller, Amy S., et al.
Publicado: (2023)

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment
por: Facheris, Paola, et al.
Publicado: (2023)

Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study
por: Riis, Jette Lindorff, et al.
Publicado: (2016)

A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis
por: Dhingra, Nikhil, et al.
Publicado: (2014)

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Effects of ambient temperature on atopic dermatitis and attributable health burden: a 6-year time-series study in Chengdu, China
por: Chen, Zerong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_brltam038nad8mvs0kuq989m97